Retinoids, vitamin D, invasion, and metastasis.
作者信息
Tokar E J, Ablin R J, Webber M M
机构信息
Inorganic Carcinogenesis Section, National Cancer Institute at the National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, U.S.A.
出版信息
Curr Oncol. 2006 Dec;13(6):198-200. doi: 10.3747/co.v13i6.120.
Abstract
摘要
相似文献
1
Retinoids, vitamin D, invasion, and metastasis.
Curr Oncol. 2006 Dec;13(6):198-200. doi: 10.3747/co.v13i6.120.
2
Chemoprevention for prostatic intraepithelial neoplasia.
Eur Urol. 1996;30(2):269-78. doi: 10.1159/000474180.
3
The role of vitamin D and retinoids in controlling prostate cancer progression.
Endocr Relat Cancer. 2003 Jun;10(2):131-40. doi: 10.1677/erc.0.0100131.
4
Strategies for chemoprevention of prostate cancer.
Prostate Cancer Prostatic Dis. 1999 Jan;2(S1):27-33. doi: 10.1038/sj.pcan.4500274.
5
Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice.
Clin Cancer Res. 2006 Oct 1;12(19):5895-901. doi: 10.1158/1078-0432.CCR-06-1039.
6
Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium.
Cancer Res. 2002 Aug 15;62(16):4812-9.
7
Evaluation of angiogenic apelin/apelin receptor axis in normal prostate, high grade prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Malays J Pathol. 2022 Dec;44(3):461-467.
8
Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model.
Mutat Res. 2001 Sep 20;496(1-2):153-61. doi: 10.1016/s1383-5718(01)00230-3.
9
Vitamin A, retinoids and carotenoids as chemopreventive agents for prostate cancer.
J Urol. 2004 Feb;171(2 Pt 2):S54-8; discussion S58. doi: 10.1097/01.ju.0000107836.08339.0a.
10
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
Oncotarget. 2017 May 30;8(22):36674-36684. doi: 10.18632/oncotarget.16230.
本文引用的文献
1
Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer.
J Exp Ther Oncol. 2006;5(4):323-33.
2
Selection of cell lines with enhanced invasive phenotype from xenografts of the human prostate cancer cell line WPE1-NB26.
J Exp Ther Oncol. 2005;5(2):111-23.
3
Stem/progenitor and intermediate cell types and the origin of human prostate cancer.
Differentiation. 2005 Dec;73(9-10):463-73. doi: 10.1111/j.1432-0436.2005.00047.x.
4
Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.
Clin Exp Metastasis. 2005;22(3):275-84. doi: 10.1007/s10585-005-8393-z.
5
Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.
Clin Exp Metastasis. 2005;22(3):265-73. doi: 10.1007/s10585-005-8394-y.
6
Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Prostate. 2001 Apr;47(1):1-13. doi: 10.1002/pros.1041.
7
Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).
Clin Exp Metastasis. 1999 May;17(3):255-63. doi: 10.1023/a:1006665616932.
8
Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
Clin Cancer Res. 1995 Jul;1(7):755-61.
9
Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
Clin Cancer Res. 1995 Jul;1(7):747-53.
10
Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells.
Carcinogenesis. 1997 Jun;18(6):1225-31. doi: 10.1093/carcin/18.6.1225.
Zotero 插件